Magnetic Resonance Imaging–Detected Intracranial Extension in the T4 Classification Nasopharyngeal Carcinoma with Intensity-Modulated Radiotherapy
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose This study was conducted is to identify the prognostic value and staging categories of magnetic resonance imaging (MRI)–detected intracranial extension in nasopharyngeal carcinoma (NPC) with intensity-modulated radiotherapy (IMRT) to determine whether it is necessary to subclassify the T4 classification NPC. Materials and Methods A total of 335 nonmetastatic T4 classification NPC patients with MRI treated between March 2004 and June 2011 by radical IMRT were included. The T4 classification patients were subclassified into two grades (T4a, without intracranial extension vs. T4b, with intracranial extension) according to the site of invasion. Results The frequency of intracranial extension was 40.9% (137 of 335 patients). Multivariate analysis identified subclassification (T4a vs. T4b) as an independent prognostic factor for local failure-free survival (p=0.049; hazard ratio [HR], 0.498) and overall survival (p=0.004; HR, 0.572); however, it had no effect on regional failure-free survival or distant failure-free survival (p > 0.050). Conclusion For patients with T4 classification NPC, those with MRI-detected intracranial extension are more likely to experience local failure and death after IMRT than patients without intracranial extension. According to the site of invasion, subclassification of T4 patients as T4a or T4b has prognostic value in NPC.
Abstract
Purpose This study was conducted is to identify the prognostic value and staging categories of magnetic resonance imaging (MRI)–detected intracranial extension in nasopharyngeal carcinoma (NPC) with intensity-modulated radiotherapy (IMRT) to determine whether it is necessary to subclassify the T4 classification NPC. Materials and Methods A total of 335 nonmetastatic T4 classification NPC patients with MRI treated between March 2004 and June 2011 by radical IMRT were included. The T4 classification patients were subclassified into two grades (T4a, without intracranial extension vs. T4b, with intracranial extension) according to the site of invasion. Results The frequency of intracranial extension was 40.9% (137 of 335 patients). Multivariate analysis identified subclassification (T4a vs. T4b) as an independent prognostic factor for local failure-free survival (p=0.049; hazard ratio [HR], 0.498) and overall survival (p=0.004; HR, 0.572); however, it had no effect on regional failure-free survival or distant failure-free survival (p > 0.050). Conclusion For patients with T4 classification NPC, those with MRI-detected intracranial extension are more likely to experience local failure and death after IMRT than patients without intracranial extension. According to the site of invasion, subclassification of T4 patients as T4a or T4b has prognostic value in NPC.
참고문헌 (23)
- Lee AW, "Management of nasopharyngeal carcinoma : current practice and future perspective", J Clin Oncol, 33, pp.3356~3364 (2015)
- Ng WT, "Staging of nasopharyngeal carcinoma : the past, the present and the future", Oral Oncol, 50, pp.549~554 (2014)
- Edge SB, "The American Joint Committee on Cancer:the 7th edition of the AJCC cancer staging manual and the future of TNM", Ann Surg Oncol, 17, pp.1471~1474 (2010)
- Chen L, "Prognostic value of subclassification using MRI in the t4 classification nasopharyngeal carcinoma intensity-modulated radiotherapy treatment", Int J Radiat Oncol Biol Phys, 84, pp.196~202 (2012)
- Lee AW, "Evolution of treatment for nasopharyngeal cancer : success and setback in the intensity-modulated radiotherapy era", Radiother Oncol, 110, pp.377~384 (2014)
- Cao CN, "Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma", Oral Oncol, 49, pp.175~181 (2013)
- Chong VF, "Nasopharyngeal carcinoma with intracranial spread : CT and MR characteristics", J Comput Assist Tomogr, 20, pp.563~569 (1996)
- Cao CN, "Update report of T4 classification nasopharyngeal carcinoma after intensity-modulated radiotherapy : an analysis of survival and treatment toxicities", Oral Oncol, 51, pp.190~194 (2015)
- Huang XD, "Multicenter phase II clinical trial of humanized anti-epidermal factor receptor monoclonal antibody h-R3 combined with radiotherapy for locoregionally advanced nasopharyngeal carcinoma", Zhonghua Zhong Liu Za Zhi, 29, pp.197~201 (2007)
- Hu YC, "Impact of intracranial extension on survival in stage IV nasopharyngeal carcinoma : identification of a subset of patients with better prognosis", Jpn J Clin Oncol, 41, pp.95~102 (2011)
- Groome PA, "A comparison of published head and neck stage groupings in carcinomas of the oral cavity", Head Neck, 23, pp.613~624 (2001)
- Sun X, "Long-term outcomes of intensity-modulated radiotherapy for 868patients with nasopharyngeal carcinoma : an analysis of survival and treatment toxicities", Radiother Oncol, 110, pp.398~403 (2014)
- Lin S, "Update report of nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy and hypothesis of the optimal margin", Radiother Oncol, 110, pp.385~389 (2014)
- Ng WT, "Clinical outcomes and patterns of failure after intensitymodulated radiotherapy for nasopharyngeal carcinoma", Int J Radiat Oncol Biol Phys, 79, pp.420~428 (2011)
- Dinshaw KA, "Radical radiotherapy in head and neck squamous cell carcinoma : an analysis of prognostic and therapeutic factors", Clin Oncol(R Coll Radiol), 18, pp.383~389 (2006)
- Liu L, "Prognostic impact of magnetic resonance imaging-detected cranial nerve involvement in nasopharyngeal carcinoma", Cancer, 115, pp.1995~2003 (2009)
- Cheng SH, "Prognostic significance of parapharyngeal space venous plexus and marrow involvement : potential landmarks of dissemination for stage I-III nasopharyngeal carcinoma", Int J Radiat Oncol Biol Phys, 61, pp.456~465 (2005)
- Hung TM, "Prognostic value of prepontine cistern invasion in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy", Oral Oncol, 50, pp.228~233 (2014)
- Loong HH, "Controversies in the systemic treatment of nasopharyngeal carcinoma", Oral Oncol, 50, pp.785~790 (2014)
- Baujat B, "Chemotherapy in locally advanced nasopharyngeal carcinoma : an individual patient data meta-analysis of eight randomized trials and 1753 patients", Int J Radiat Oncol Biol Phys, 64, pp.47~56 (2006)
- Langendijk JA, "The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature", J Clin Oncol, 22, pp.4604~4612 (2004)
- Blanchard P, "Chemotherapy and radiotherapy in nasopharyngeal carcinoma : an update of the MAC-NPC meta-analysis", Lancet Oncol, 16, pp.645~655 (2015)
- Niu X, "Using neoadjuvant chemotherapy and replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma with intracranial invasion to protect critical normal tissue", Radiat Oncol, 8, pp.226~ (2013)